Overview

Update
Status
Acquired by on August 13, 2010
Total Equity Funding
$93M in 2 Rounds from 5 Investors
Headquarters:
South San Francisco, CA
Description:
Solstice Neurosciences is focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products.
Categories:
Marketing, Biotechnology, Manufacturing
Website:
http://www.solsticeneuro.com

Company Details

Update

Solstice Neurosciences is a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. Solstice's first product named Myobloc® (rimabotulinumtoxinB) Injection in the U.S. and NeuroBloc® (Botulinum Toxin Type B) Injectable Solution in select overseas markets, represents the only botulinum toxin type B currently available to physicians and patients worldwide.

Funding Rounds (2) - $93M

Update
DateAmount / RoundValuationLead InvestorInvestors
Nov, 2006$85M / Series B5
Jul, 2005$8M / Venture4

News (3)

Update
DateNews
Oct 15, 2013usworldmeds.com - US WorldMeds - Press Releases
Apr 19, 2010solsticeneuro.com - Solstice Neurosciences raises 85000000 in venture round
Nov 9, 2006PE HUB - Solstice Nets $85 Million

Offices/Locations (1)

Update
  • Office

    701 Gateway Boulevard

    Suite 250

    South San Francisco, CA 94080

    USA

Images (1)

Update

Add Acquisitions

Add Current Team

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos